| 2025-08-04 |
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. |
Ainos Receives TFDA Approval to Initiate Clinical Study of VELDONA for Primary Sjögren's Syndrome ainos.com ↗ |
| 2025-05-19 |
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. |
Ainos Reports Breakthrough Interim Results in VELDONA Clinical Trial for FCGS, Signaling New Era in Companion Animal Immunotherapy ainos.com ↗ |
| 2025-04-14 |
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. |
Ainos Secures TFDA Approval and IRB Clearance to Advance VELDONA Clinical Trials for HIV Oral Warts and Sjögren's Syndrome in Taiwan ainos.com ↗ |
| 2025-01-27 |
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. |
Ainos Achieves Major Breakthrough: Japan Patent Approval for VELDONA Redefines Antiviral Innovation ainos.com ↗ |
| 2024-12-18 |
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. |
Smell the Future: Ainos Elevates Health and Technology With AI Nose and VELDONA ainos.com ↗ |
| 2024-10-07 |
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. |
Ainos Advances Healthcare and Industrial Innovations with AI Nose and VELDONA Technologies ainos.com ↗ |
| 2024-09-25 |
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. |
Ainos, Inc. Receives IRB Approval From National Taiwan University Hospital for HIV-Oral Warts Clinical Trial, Highlighting Value of FDA-Designated Orphan Drug VELDONA ainos.com ↗ |
| 2024-09-23 |
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. |
Ainos Announced Plan to Initiate Taiwan Clinical Study of VELDONA for Treating Sjögren's Syndrome, a Rare Disease With Limited Treatment Options ainos.com ↗ |
| 2024-09-17 |
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. |
Ainos Announced Plan to Initiate Taiwan Clinical Study for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA ainos.com ↗ |
| 2024-09-03 |
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. |
Ainos Secures Taiwan Invention Patent and Advances Global Patent Protection for VELDONA, a Breakthrough in Coronavirus Treatment and Prevention ainos.com ↗ |
| 2024-07-26 |
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. |
Ainos Enrolls First Subject for Clinical Study of VELDONA-Based Animal FCGS Drug ainos.com ↗ |
| 2024-05-15 |
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. |
Ainos to Initiate Clinical Study of New Potential VELDONA-Based Animal Drug, Expanding VELDONA's Potential Market ainos.com ↗ |
| 2024-02-05 |
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. |
Ainos Submits Clinical Hold Complete Response to US FDA to Resolve the Deficiencies on Investigational New Drug Phase II Trial of its VELDONA Formulation Against Mild COVID-19 Symptoms ainos.com ↗ |
| 2023-11-28 |
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. |
Ainos Announces Successful Manufacturing of VELDONA GMP Clinical Batch by Swiss Pharmaceutical ainos.com ↗ |
| 2023-11-21 |
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. |
Ainos Announces Positive Data Reported from its Clinical Studies for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA ainos.com ↗ |
| 2023-11-06 |
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. |
Ainos Signs MoU for Contract Clinical Trials to Conduct Clinical Study of Potential New Animal Drug Based on VELDONA ainos.com ↗ |
| 2023-09-18 |
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. |
Ainos VELDONA Granted Orphan Drug Designation by U.S. FDA for Potential Treatment of Oral Warts in HIV-Seropositive Patients ainos.com ↗ |
| 2023-09-05 |
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. |
Ainos Commences Shipping its VELDONA Pet Cytoprotein Supplements in Taiwan ainos.com ↗ |
| 2023-06-14 |
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. |
Ainos Completes VELDONA Pet Line-Up by Launching New VELDONA Pet Shiny and Slim in Push Towards $20M Revenue Target ainos.com ↗ |
| 2023-06-07 |
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. |
Ainos Launches New VELDONA Pet Lohas and Soothing Health Supplements, Catalyzing Its Drive to $20M Sales Target ainos.com ↗ |
| 2023-05-30 |
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. |
Ainos Launches VELDONA Pet Cytoprotein Health Supplement Targeting $20M in Sales ainos.com ↗ |
| 2023-03-21 |
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. |
Ainos Signs Agreement Establishing Topmed as Exclusive Distributor of VELDONA Animal Health Supplements in Taiwan ainos.com ↗ |
| 2023-03-14 |
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. |
Ainos and Merdury Sign MoU to Explore Phase 3 Study of VELDONA Drug Candidate for Treatment of Oral Warts in HIV-Seropositive Patients ainos.com ↗ |
| 2023-01-23 |
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. |
Ainos and Tah-An Sign MoU to Explore Manufacture of VELDONA Animal Investigational New Drug ainos.com ↗ |
| 2022-11-25 |
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. |
Ainos Publishes Preclinical Data Demonstrating its VELDONA Formulation's Potential as Treatment Candidates for the Most Common Medical Conditions for Companion Animals ainos.com ↗ |
| 2022-08-24 |
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. |
Ainos Submits Investigational New Drug Application to the U.S. FDA to Conduct Phase 2 Trial of its VELDONA Low-dose Oral Interferon Formulation Against Mild COVID-19 Symptoms ainos.com ↗ |
| 2022-08-17 |
Ainos, Inc. (f/k/a Amarillo Biosciences Inc. |
Ainos Announces Master Services Agreement with Swiss Pharmaceutical, Ltd. for Drug Testing, Manufacturing, and Packaging for its VELDONA Product Candidates ainos.com ↗ |
|